# Hyaluronidase Effect on Infusion Set Life

> **NCT02199028** · PHASE1 · COMPLETED · sponsor: **Stanford University** · enrollment: 30 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** Hyaluronidase
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT02199028
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-10-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02199028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02199028, "Hyaluronidase Effect on Infusion Set Life". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02199028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*